(Received for publication February 12, 1985) Mother liquors from steffimycin B crystallizations have been processed to yield steffimycin C, a new member of the steffimycin family of anthracyclines. It has been identified, using spectroscopic methods, as 10-deoxysteffimycin B. Steffimycin C has antibacterial activity only against Streptococcus pneumoniae. Whether steffimycin C is a precursor of steffimycin B or a metabolic reduction product is unknown at this time.
In 1967 BERGY and REUSSER'> reported the isolation and chemical characterization of steffimycin (I), a novel anthracycline antibiotic. Aranciamycin (II), the second member of the family was reported in 19702). In 1974, BRODASKY and REUSSER3) described the isolation and characterization of the third member of this family, steffimycin B (III). II (Aranciamycin) R, =H, R,=H III (Steffimycin B) R,=CH3, R3=CH, stationary phase was silica gel and the mobile phase consisted of MeOH -CH3CN -H2O -CHCI3 -(C2H5)3N (61: 26: 5: 7: 0.7). 2 g of solid was dissolved in a minimum volume of mobile phase for each run. The fractions containing steffimycin C (by TLC analysis) were pooled and concentrated to an aqueous phase. After adjusting the pH of the aqueous phase to 7 with HCI, the steffimycin C was extracted into EtOAc. Crude steffimycin C was obtained by precipitation from the EtOAc with excess cyclohexane. TLC analysis of the precipitate on Whatman (Whatman, Clifton, New Jersey) linear high performance silica gel plates using a mobile phase of CH2CI2 -(CH3)2CO -C,H,, -MeOH (30: 10: 3 : 2) revealed the presence of steffimycin C and 5 -10 % of steffimycin B.
Purification of Crude Steffimycin C Crude steffimycin C was further purified by column chromatography on a Merck (E. Merck
Darmstardt, Germany) prepacked silica gel column (bed volume 473 ml) using a mobile phase composed of CH2Cl2 -(CH3)2CO -C,H,, -MeOH (30: 10: 3: 2). For a typical run, 0.7 g of crude steffimycin C was dissolved in a minimum volume of mobile phase and the solution was charged onto the column which was subsequently eluted with the above mobile phase at a linear velocity of 1 cm/minute. Eleven fractions (10 ml each) were collected on the basis of color banding. Using TLC analysis, those fractions containing steffimycin C with a minimum of steffimycin B contaminant were pooled. Evaporation of the solvent from the pool resulted in the isolation of 0.3 g of steffimycin C whose purity, by TLC, was estimated as >98%. This material was suitable for spectroscopic characterization but to verify the antibacterial behavior of steffimycin C, a small amount of the purified material was chromatographed on a Whatman high performance TLC plate using the above mobile phase. The Nujol mull IR spectrum of steffimycin C is given in Fig. 1 and it is characterized by the absence of the strong 1750 cm-1/carbonyl band found in the spectrum of steffimycin B. A significant change in the 200-300 nm region of the UV spectrum of steffimycin C compared with steffimycin B, Fig. 2 , was also observed. The absorption maxima and log s values for steffimycin C appear in Table   1 . These spectral data are consistent with the alteration or loss of a carbonyl group in the steffimycin B structure resulting in steffimycin C.
The 13C NMR spectrum of steffimycin C in DMSO referenced to TMS is given in Fig. 3 . Off resonance experiments allowed determination of line multiplicities and led to the correlation diagram shown in Fig. 4 . Line positions and multiplicities for both compounds are given in Table 2 . is shown in Fig. 6 . The appearance of the strong line at 42.1 ppm supports structure VI for steffimycin C. ring/double bond number of 13. These data are consistent with structure VI for steffimycin C.
The difference in specific activity of the two antibiotics was measured using the biounit potency assay'). One mg/ml CH,C12 solutions of the antibiotics were serially diluted I to 2 down to a dilution of 1/128 and 80 Id of each solution was applied to 12.5 mm paper discs. After drying, the discs were applied to an agar tray seeded with Micrococcus htteus UC 130. The trays were incubated for 16 hours at 32°C and the resulting zones of antibiotics were read to the nearest mm.
These data were subjected to regression analysis using a Hewlett Packard model 85A microcomputer.
The dilutions necessary to give a 20-mm zone of inhibition were interpolated from the regression lines and converted to biounits, 
